Imaging Study in Metastatic UC, HR+ and HER2- Breast Cancer, TNBC, and NSCLC

NCT07671092 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Urothelial Carcinoma
Breast Cancer
TNBC - Triple-Negative Breast Cancer
Hormone Receptor Positive HER-2 Negative Breast Cancer
NSCLC

Interventions

DIAGNOSTIC_TEST: RYZ211/212

Sponsor

RayzeBio, Inc.